ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	32/274	191/7206	6.85195944102e-13
ko04380	Osteoclast differentiation	26/274	134/7206	3.52552117965e-12
ko04610	Complement and coagulation cascades	17/274	79/7206	4.23229906408e-09
ko05150	Staphylococcus aureus infection	10/274	36/7206	5.67659468225e-07
ko05140	Leishmaniasis	14/274	75/7206	6.60890596178e-07
ko05164	Influenza A	21/274	167/7206	1.19002917536e-06
ko05152	Tuberculosis	22/274	187/7206	2.05934215074e-06
ko05162	Measles	17/274	120/7206	2.45864971316e-06
ko04650	Natural killer cell mediated cytotoxicity	15/274	97/7206	3.20088019838e-06
ko04621	NOD-like receptor signaling pathway	19/274	157/7206	6.90491990698e-06
ko04672	Intestinal immune network for IgA production	9/274	37/7206	7.10207836911e-06
ko05340	Primary immunodeficiency	8/274	30/7206	1.11347466821e-05
ko05321	Inflammatory bowel disease (IBD)	10/274	56/7206	4.05378514856e-05
ko05145	Toxoplasmosis	15/274	126/7206	7.89024806201e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	19/274	191/7206	0.000109644108215
ko04630	Jak-STAT signaling pathway	15/274	132/7206	0.000134557476175
ko04933	AGE-RAGE signaling pathway in diabetic complications	15/274	135/7206	0.000173417059973
ko04659	Th17 cell differentiation	13/274	106/7206	0.000174730431905
ko05168	Herpes simplex infection	18/274	182/7206	0.000179043477002
ko05132	Salmonella infection	12/274	98/7206	0.000314172038651
ko04611	Platelet activation	16/274	163/7206	0.000444585998217
ko05160	Hepatitis C	15/274	153/7206	0.000676746697091
ko04666	Fc gamma R-mediated phagocytosis	13/274	122/7206	0.000700799142126
ko04217	Necroptosis	16/274	178/7206	0.00116396464922
ko04620	Toll-like receptor signaling pathway	11/274	100/7206	0.00137603208066
ko04662	B cell receptor signaling pathway	10/274	88/7206	0.00176111288123
ko04612	Antigen processing and presentation	9/274	77/7206	0.00243541801527
ko04664	Fc epsilon RI signaling pathway	9/274	77/7206	0.00243541801527
ko04660	T cell receptor signaling pathway	12/274	124/7206	0.0025628906715
ko04640	Hematopoietic cell lineage	8/274	64/7206	0.00274798750772
ko04658	Th1 and Th2 cell differentiation	10/274	96/7206	0.0033728779598
ko05161	Hepatitis B	15/274	173/7206	0.00347965308389
ko04062	Chemokine signaling pathway	16/274	201/7206	0.00440110633725
ko05166	HTLV-I infection	21/274	292/7206	0.00440407118842
ko04145	Phagosome	14/274	162/7206	0.00510130441386
ko05133	Pertussis	9/274	87/7206	0.00556967277854
ko04668	TNF signaling pathway	11/274	120/7206	0.00577771242723
ko00120	Primary bile acid biosynthesis	4/274	20/7206	0.00611924402751
ko05323	Rheumatoid arthritis	9/274	89/7206	0.00646306583058
ko05144	Malaria	6/274	45/7206	0.00669326854031
ko05034	Alcoholism	2/274	238/7206	0.00891545358888
ko04064	NF-kappa B signaling pathway	9/274	96/7206	0.0104787397664
ko04072	Phospholipase D signaling pathway	15/274	197/7206	0.0118189915079
ko05330	Allograft rejection	4/274	24/7206	0.0119138296852
ko05131	Shigellosis	8/274	82/7206	0.0123191365471
ko05212	Pancreatic cancer	8/274	83/7206	0.0131988980025
ko04144	Endocytosis	22/274	342/7206	0.013410090452
ko05142	Chagas disease (American trypanosomiasis)	11/274	130/7206	0.0165529905358
ko05202	Transcriptional misregulation in cancer	14/274	188/7206	0.0175328207217
ko05320	Autoimmune thyroid disease	4/274	29/7206	0.0229678507922
ko04015	Rap1 signaling pathway	18/274	278/7206	0.0241646022484
ko05310	Asthma	3/274	17/7206	0.0249007647927
ko05332	Graft-versus-host disease	3/274	18/7206	0.0290603337406
ko04622	RIG-I-like receptor signaling pathway	6/274	62/7206	0.0296382343332
ko04670	Leukocyte transendothelial migration	11/274	151/7206	0.0312819265651
ko05012	Parkinson's disease	1/274	155/7206	0.0314914824082
ko05215	Prostate cancer	9/274	111/7206	0.0381108407353
ko05169	Epstein-Barr virus infection	14/274	206/7206	0.0384081453736
ko05200	Pathways in cancer	27/274	492/7206	0.0499534835833